Clinical Trial Update: Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of a study evaluating self-administration of AOP2014 via a pen for polycythemia vera.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• AOP2014

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Polycythemia Vera | Phase 3 | Status: COMPLETED